Tag Archives: Pfizer

Why Is the FDA Hiding the Pfizer Vaccine Data?

Despite the FDA’s claim that it is committed to transparency, especially for COVID-19 emergency use authorizations (EUAs),1 the agency first requested 55 years to release the data supporting the approval of Comirnaty after a Freedom of Information Act (FOIA) request was filed,2 and then asked for an extra 20 years to fully comply.3 Pfizer has… Read More »

Pfizer Vaccine Protection Wanes After 6 Months Study Finds

July 28, 2021 – Pfizer’s COVID-19 vaccine continues to show strong protection against serious illness and hospitalization after 6 months, but overall protection against the virus appears to wane after a half a year, according to a new study. The July 28, 2021, pre-print report of the study, which has not been peer-reviewed, suggests a… Read More »

Pfizer lays out COVID-19 vaccine commercial strategy for pandemic and beyond

With its trials and pricing set, Pfizer has pulled back the curtain on the long-range commercial strategy for its COVID-19 vaccine. During its earnings call Tuesday, execs laid out two phases, pandemic and seasonal, with some combination of the two likely to play out over the next several years. The current pandemic phase, expected to continue… Read More »

After positive early data, Pfizer, BioNTech CEOs sound off on coronavirus vaccine timelines

On the heels of early positive COVID-19 vaccine data, the CEOs at BioNTech and Pfizer are gearing up for a late-stage trial and talking up potential approvals later this year.  In separate interviews this week, Pfizer CEO Albert Bourla and BioNTech CEO Ugur Sahin said their mRNA vaccine candidate could be ready to submit to regulators in the fall or winter, respectively, pending success in… Read More »